Literature DB >> 18673266

Floating microspheres as drug delivery system: newer approaches.

Sunil K Jain1, Govind P Agrawal, Narendra K Jain.   

Abstract

A controlled drug delivery system with prolonged residence time in the stomach can be of great practical importance for drugs with an absorption window in the upper small intestine. The main limitations are attributed to the inter- and intra-subject variability of gastro-intestinal (GI) transit time and the non-uniformity of drug absorption throughout the alimentary canal. Floating drug delivery systems (FDDSs) are expected to remain buoyant in a lasting way upon the gastric contents and consequently to enhance the bioavailability of drugs. The various buoyant preparations include hollow microspheres, granules, powders, tablets, capsules, pills and laminated films. Floating microspheres are specially gaining attention due to their wide applicability in the targeting of drugs to stomach. These floating microspheres have the advantage that they remain buoyant and distributed uniformly over the gastric fluid to avoid the vagaries of gastric emptying and release the drug for prolonged period of time. A major drawback of low-density floating drug delivery systems is that their performance is strongly dependent upon the gastric emptying process of stomach. Multiparticulate low-density particles can successfully prolong the gastric retention time of drugs. This article is a review of two important approaches utilized to prepare and improve the performance of floating microspheres.

Mesh:

Substances:

Year:  2008        PMID: 18673266     DOI: 10.2174/156720108784911721

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  1 in total

1.  Development and evaluation of a floating multiparticulate gastroretentive system for modified release of AZT.

Authors:  Valquíria Miwa Hanai Yoshida; José Martins de Oliveira Junior; Marcos Moisés Gonçalves; Marta Maria Duarte Carvalho Vila; Marco Vinícius Chaud
Journal:  AAPS PharmSciTech       Date:  2011-05-12       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.